CVS Health Q1 2022 Earnings Report
Key Takeaways
CVS Health reported a strong first quarter with total revenues increasing by 11.2% to $76.8 billion. GAAP diluted EPS was $1.74, and adjusted EPS was $2.22. The company generated $3.6 billion in cash flow from operations and raised its full-year adjusted EPS guidance.
Total revenues increased to $76.8 billion, up 11.2% compared to prior year.
GAAP diluted EPS of $1.74 and Adjusted EPS of $2.22.
Generated cash flow from operations of $3.6 billion.
Raised Adjusted EPS guidance range to $8.20 to $8.40 from $8.10 to $8.30.
CVS Health
CVS Health
CVS Health Revenue by Segment
Forward Guidance
The Company revised its full-year 2022 GAAP diluted EPS guidance range to $6.93 to $7.13 from $7.04 to $7.24 and raised its full-year 2022 Adjusted EPS guidance range to $8.20 to $8.40 from $8.10 to $8.30. The Company also confirmed its full-year 2022 cash flow from operations guidance range of $12.0 billion to $13.0 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income